1. Home
  2. FEMY vs WVVI Comparison

FEMY vs WVVI Comparison

Compare FEMY & WVVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FEMY
  • WVVI
  • Stock Information
  • Founded
  • FEMY 2004
  • WVVI 1983
  • Country
  • FEMY United States
  • WVVI United States
  • Employees
  • FEMY N/A
  • WVVI N/A
  • Industry
  • FEMY Medical/Dental Instruments
  • WVVI Beverages (Production/Distribution)
  • Sector
  • FEMY Health Care
  • WVVI Consumer Staples
  • Exchange
  • FEMY Nasdaq
  • WVVI Nasdaq
  • Market Cap
  • FEMY 31.9M
  • WVVI 28.2M
  • IPO Year
  • FEMY 2021
  • WVVI N/A
  • Fundamental
  • Price
  • FEMY $0.91
  • WVVI $5.39
  • Analyst Decision
  • FEMY Strong Buy
  • WVVI
  • Analyst Count
  • FEMY 3
  • WVVI 0
  • Target Price
  • FEMY $8.67
  • WVVI N/A
  • AVG Volume (30 Days)
  • FEMY 280.4K
  • WVVI 25.7K
  • Earning Date
  • FEMY 08-07-2025
  • WVVI 08-12-2025
  • Dividend Yield
  • FEMY N/A
  • WVVI N/A
  • EPS Growth
  • FEMY N/A
  • WVVI N/A
  • EPS
  • FEMY N/A
  • WVVI N/A
  • Revenue
  • FEMY $1,699,232.00
  • WVVI $38,520,945.00
  • Revenue This Year
  • FEMY $231.84
  • WVVI N/A
  • Revenue Next Year
  • FEMY $245.28
  • WVVI N/A
  • P/E Ratio
  • FEMY N/A
  • WVVI N/A
  • Revenue Growth
  • FEMY 61.97
  • WVVI N/A
  • 52 Week Low
  • FEMY $0.69
  • WVVI $3.17
  • 52 Week High
  • FEMY $1.80
  • WVVI $7.18
  • Technical
  • Relative Strength Index (RSI)
  • FEMY 50.88
  • WVVI 44.29
  • Support Level
  • FEMY $0.90
  • WVVI $5.22
  • Resistance Level
  • FEMY $0.99
  • WVVI $5.75
  • Average True Range (ATR)
  • FEMY 0.07
  • WVVI 0.40
  • MACD
  • FEMY 0.01
  • WVVI 0.01
  • Stochastic Oscillator
  • FEMY 39.48
  • WVVI 57.57

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

About WVVI Willamette Valley Vineyards Inc.

Willamette Valley Vineyards Inc produces and sells premium, super-premium, and ultra-premium wines. The grapes are harvested, fermented, and made into wine at the company's Turner winery, and the wines are sold principally under its Willamette Valley Vineyards label and also under the Griffin Creek, Tualatin Estate, Pambrun, Maison Bleue, Natoma, Metis, and Elton labels. It operates under two operating segments, direct sales and distributor sales. Direct sales include retail sales in its tasting room and remote sites, wine club sales, online sales, on-site events, kitchen and catering sales, and other sales made directly to the consumer without the use of an intermediary. Distributor sales include all sales through a third party where prices are given at a wholesale rate.

Share on Social Networks: